CURI BIO, INC.
Seattle, WA · Medtech · Private
Tissue chip platform integrating iPSC-derived motor neurons and muscle cells with electrode-based stimulation and magnetic contraction measurement for neuromuscular junction functional assays
curibio.com →- Grants
- $11M
- 28 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 26
- 3 granted · 23 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · High-throughput nanoMEA-based Proarrhythmia Assay | $214,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · A Nanopatterned Interdigitated Electrode Array Device for Anti migratory Cancer Drug Screening | $225,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · A Nanopatterned Interdigitated Electrode Array Device for Anti-migratory Cancer Drug Screening | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · High-throughput nanoMEA-based Proarrhythmia Assay | $748,435 | |
| Federal grant | Department of Health and Human Services · Phase I · A Combinatorial Bioreactor for Electromechanical Conditioning of Differentiated Stem Cells | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · High-throughput nanoMEA-based Proarrhythmia Assay | $747,868 | |
| Federal grant | Department of Health and Human Services · Phase II · High-throughput nanoMEA-based Proarrhythmia Assay | $123,510 | |
| Federal grant | Department of Health and Human Services · Phase II · High-throughput nanoMEA-based Proarrhythmia Assay | $129,050 | |
| Federal grant | Department of Health and Human Services · Phase II · Bioengineering Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes for Predictive Drug-Induced Toxicity Testing | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Low-cost, Roll-to-Roll Manufacturing of Nanoscale Biomimetic Scaffolds for Enhanced Biological Cell Culture | $221,713 | |
| Federal grant | Department of Health and Human Services · Phase I · Multiplexed quantitative measurements of field potential and contractility on biomimetically-matured hPSC-CMs | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Bioengineering Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes for Predictive Drug-Induced Toxicity Testing | $750,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Maturation of stem cell-derived cardiomyocytes using a simulated microgravity bioreactor and combinations of extracellular developmental cues | $252,131 | |
| Federal grant | Department of Health and Human Services · Phase II · Predictive assessment of acute and chronic cardiotoxicity using combinatorially matured hPSC-CMs | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Cryopreserving Stem Cell-Derived Cardiomyocytes in Ready-to-use Assay Plates for Improved Reproducibility of Drug Toxicity Testing | $252,131 | |
| Federal grant | Department of Health and Human Services · Phase II · Bioengineering Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes for Predictive Drug-Induced Toxicity Testing | $69,068 | |
| Federal grant | Department of Health and Human Services · Phase II · Bioengineering Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes for Predictive Drug-Induced Toxicity Testing | $745,488 | |
| Federal grant | Department of Health and Human Services · Phase II · Bioengineering Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes for Predictive Drug-Induced Toxicity Testing | $179,200 | |
| Federal grant | Department of Health and Human Services · Phase II · Predictive assessment of acute and chronic cardiotoxicity using combinatorially matured hPSC-CMs | $750,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Predictive assessment of acute and chronic cardiotoxicity using combinatorially matured hPSC-CMs | $123,144 | |
| Federal grant | Department of Health and Human Services · Phase II · Predictive assessment of acute and chronic cardiotoxicity using combinatorially matured hPSC-CMs | $750,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Predictive assessment of acute and chronic cardiotoxicity using combinatorially matured hPSC-CMs | $242,088 | |
| Federal grant | Department of Health and Human Services · Phase II · Predictive assessment of acute and chronic cardiotoxicity using combinatorially matured hPSC-CMs | $169,156 | |
| Federal grant | Department of Health and Human Services · Phase II · A cross-species preclinical platform to enhance the translation of new medicines | $324,648 | |
| Federal grant | Department of Health and Human Services · Phase I · A cross-species preclinical platform to enhance the translation of new medicines | $324,648 | |
| Federal grant | Department of Health and Human Services · Phase I · High-Throughput NMJ Assay for Botox Potency Screening | $275,766 | |
| Federal grant | Department of Health and Human Services · Phase II · A cross-species preclinical platform to enhance the translation of new medicines | $832,365 | |
| Federal grant | Department of Health and Human Services · Phase II · A cross-species preclinical platform to enhance the translation of new medicines | $1,149,771 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1523 | SeeMedX, Inc. | — | $8.5M |
| 1524 | NED Medical, Inc. | — | $8.5M |
| 1525 | ELITE ATHLETE PRODUCTS INC | — | — |
| 1526 | CURI BIO, INC. | — | — |
| 1527 | Caeli Vascular LLC | — | — |
| 1528 | CAMELLIX, LLC | — | — |
| 1529 | Apex Cool Labs, Inc. | — | $65K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Devices And Methods For The Generation And Evaluation Of Engineered Tissuesgranted
- Devices And Methods For Static And Dynamic Tissue Modulationapplication
- Devices And Methods For Magnetic Detection Of Tissue Motiongranted
- System And Methods For In Vitro Structural Toxicity Testinggranted
- Devices And Methods For The Generation And Evaluation Of Engineered Tissuesapplication
- Systems, Devices, And Methods For Analysis Of Biological Samplesapplication
- Devices And Methods For Guiding Cells And Monitoring Electrical Activitiesapplication
- Musculoskeletal and Neuromuscular Systems and Methods for Functional Interrogation Thereofapplication
- Devices And Methods For Static And Dynamic Tissue Modulationapplication
- Musculoskeletal and Neuromuscular Systems and Methods for Functional Interrogation Thereofapplication
- Devices And Methods For Static And Dynamic Tissue Modulationapplication
- Optoreactive Tissue Stimulation Systemsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.